Walter M. Stadler to Carcinoma, Papillary
This is a "connection" page, showing publications Walter M. Stadler has written about Carcinoma, Papillary.
Connection Strength
0.559
-
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer. Clin Genitourin Cancer. 2008 Mar; 6(1):21-4.
Score: 0.286
-
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Cancer. 2017 Dec 01; 123(23):4566-4573.
Score: 0.138
-
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma. Clin Genitourin Cancer. 2009 Jan; 7(1):39-42.
Score: 0.076
-
A molecular classification of papillary renal cell carcinoma. Cancer Res. 2005 Jul 01; 65(13):5628-37.
Score: 0.059